[
  {
    "ts": null,
    "headline": "Foley Catheters Global Forecast Report 2025-2030: $1.2 Billion Market Driven by Innovative Designs, Smart Catheter Development, and Expanding Healthcare Infrastructure in Emerging Markets",
    "summary": "The global Foley catheters market is anticipated to grow to USD 1.20 billion by 2030, from USD 931.0 million in 2025, at a CAGR of 5.3%. This growth is fueled by increasing urological disorders, rising surgical volumes, and improved healthcare infrastructure in emerging economies. A surge in demand is noted for 5 mL balloons due to their comfort in catheterization. While latex catheters dominate due to cost-effectiveness, Europe's advanced healthcare drives the largest regional market share. Top",
    "url": "https://finnhub.io/api/news?id=848877e7438284322cfebe8ec0eaafe4def03e6744b003ae542f16b701975503",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762258620,
      "headline": "Foley Catheters Global Forecast Report 2025-2030: $1.2 Billion Market Driven by Innovative Designs, Smart Catheter Development, and Expanding Healthcare Infrastructure in Emerging Markets",
      "id": 137312752,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "The global Foley catheters market is anticipated to grow to USD 1.20 billion by 2030, from USD 931.0 million in 2025, at a CAGR of 5.3%. This growth is fueled by increasing urological disorders, rising surgical volumes, and improved healthcare infrastructure in emerging economies. A surge in demand is noted for 5 mL balloons due to their comfort in catheterization. While latex catheters dominate due to cost-effectiveness, Europe's advanced healthcare drives the largest regional market share. Top",
      "url": "https://finnhub.io/api/news?id=848877e7438284322cfebe8ec0eaafe4def03e6744b003ae542f16b701975503"
    }
  },
  {
    "ts": null,
    "headline": "BD Achieves Milestone in AGILITY Study of Revello™ Vascular Covered Stent for Treatment of Peripheral Artery Disease",
    "summary": "BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced full enrollment of the iliac artery patient cohort in its pivotal AGILITY Investigational Device Exemption (IDE) study, a prospective, multi-center study evaluating the Revello™ Vascular Covered Stent in patients with peripheral arterial disease (PAD).",
    "url": "https://finnhub.io/api/news?id=e330da52da5c35c81557b88e38338b7c6d329b05175d4ea3a725fe9a8d970e0b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762257000,
      "headline": "BD Achieves Milestone in AGILITY Study of Revello™ Vascular Covered Stent for Treatment of Peripheral Artery Disease",
      "id": 137312753,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced full enrollment of the iliac artery patient cohort in its pivotal AGILITY Investigational Device Exemption (IDE) study, a prospective, multi-center study evaluating the Revello™ Vascular Covered Stent in patients with peripheral arterial disease (PAD).",
      "url": "https://finnhub.io/api/news?id=e330da52da5c35c81557b88e38338b7c6d329b05175d4ea3a725fe9a8d970e0b"
    }
  }
]